Valion Bio Inc (VBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,002 | 2,189 | 3,693 | 1,668 | 3,395 |
| Receivables | N/A | 9 | 16 | 74 | 174 |
| Inventories | N/A | 731 | 766 | 774 | 756 |
| Other current assets | 397 | 0 | 0 | 61 | 0 |
| TOTAL | $2,639 | $3,163 | $4,663 | $2,827 | $4,652 |
| Non-Current Assets | |||||
| PPE Net | 2 | 119 | 120 | 121 | 122 |
| Other Non-Current Assets | 166 | 112 | 0 | 338 | 383 |
| TOTAL | $168 | $231 | $120 | $459 | $505 |
| Total Assets | $2,807 | $3,394 | $4,783 | $3,286 | $5,157 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 125 | 333 | 446 | 547 | 713 |
| TOTAL | $272 | $560 | $591 | $992 | $1,401 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 141 | 176 |
| TOTAL | $N/A | $N/A | $N/A | $141 | $176 |
| Total Liabilities | $272 | $560 | $591 | $1,133 | $1,577 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 620 | 486 | 364 | 364 | 86 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -43,541 | -42,064 | -40,633 | -39,367 | -37,886 |
| TOTAL | $2,535 | $2,834 | $4,192 | $2,153 | $3,580 |
| Total Liabilities And Equity | $2,807 | $3,394 | $4,783 | $3,286 | $5,157 |